Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in ménière's disease in a European Caucasian Population

DNA and Cell Biology

Volumn 30, Issue 9, 2011, Pages 699-708

  Gazquez, Irene ^a   Lopez Escamez, Jose A ^a,b   Moreno, Antonia ^a   Campbell, Colleen A ^c   Meyer, Nicole C ^c   Carey, John P ^d   Minor, Lloyd B ^d   Gantz, Bruce J ^c   Hansen, Marlan R ^c   Santina, Charles C Della ^d   Aran, Ismael ^e   Soto Varela, Andres ^f   Santos, Sofia ^f   Batuecas, Angel ^g   Perez Garrigues, Herminio ^h   Lopez Nevot, Alicia ^a   Smith, Richard J H ^c   Lopez Nevot, Miguel A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL DE PONIENTE   (Spain)

^c UNIVERSITY OF IOWA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Johns Hopkins University ^*  (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE A; MICROSATELLITE DNA; NEURONAL NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEARING LOSS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; UNITED STATES;

BASE SEQUENCE; BINDING SITES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HEARING LOSS, SENSORINEURAL; HUMANS; MENIERE DISEASE; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SPAIN; UNITED STATES;

CAVIA;

EID: 80052844037     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1259     Document Type: Article

References (46)

1. Anne, S., Kisley, L.B., Tajuddin, S.T., Leahy, P., Alagramam, K.N., and Megerian, C.A. (2007). Molecular changes associated with the endolymphatic hydrops model. Otol Neurotol 28, 834-841. (Pubitemid 47329901)
2. Bixenstine, P.J., Maniglia, M.P., Vasanji, A., Alagramam, K.N., and Megerian, C.A. (2008) Spiral ganglion degeneration patterns in endolymphatic hydrops. Laryngoscope 118, 12171223.
3. Bogdan, C. (2001). Nitric oxide and the immune response. Nat Immunol 2, 907-916. (Pubitemid 32976162)
4. Boissel, J.P., Zelenka, M., Godtel-Armbrust, U., Feuerstein, T.J., Forstermann, U. (2003). Transcription of different exons 1 of the human neuronal nitric oxide synthase gene is dynamically regulated in a cell- and stimulus-specific manner. Biol Chem 384, 351-362. (Pubitemid 36527642)
5. Bredt, D.S. (2003). Nitric oxide signaling specificity-the heart of the problem. J Cell Sci 116, 9-15. (Pubitemid 36113960)
6. Bros, M., Boissel, J.P., Godtel-Armbrust, U., and Forstermann, U. (2006). Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87, 463-473.
7. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butter- field, D.A., and Stella, A.M. (2007). Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8, 766-775. (Pubitemid 47462116)
8. Campbell, C.A., Della Santina, C.C., Meyer, N.C., Smith, N.B, Myrie, O.A., Stone, E.M., Fukushima, K., Califano, J., Carey, J.P., Hansen, M.R., Gantz B.J., Minor, L.B., and Smith R.J.H. (2010). Polymorphisms in KCNE1 or KCNE3 are not associated with Meniere disease in the caucasian population. Am J Med Genet Part A 152A, 67-74.
9. Campbell, C.D., Ogburn, E.L., Lunetta, K.L., Lyon, H.N., Freedman, M.L., Groop, L.C., Altshuler, D., Ardie, K.G., and Hirschhorn JN. (2005). Demonstrating stratification in a European American population. Nat Genet 37, 868-872. (Pubitemid 41077113)
10. Cui, H., Nishiguchi, N., Yanagi, M., Fukutake, M., Mouri, K., Kitamura, N., Hashimoto, T., Shirakawa, O., and Hishimoto, A. (2010). A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunore- activity in the postmortem brain. Schizophrenia Res 121, 172178.
11. Doi, K., Sato, T., Kuramasu, T., Hibino, H., Kitahara, T., Horii, A., Matsushiro, N., Fuse, Y., and Kubo, T. (2005). Meniere's disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec 67, 289-293. (Pubitemid 43004461)
12. Fessenden, J.D., Altschuler, R.A., Seasholtz, A.F., and Schacht, J. (1999). Nitric oxide/cyclic guanosine monophosphate pathway in the peripheral and central auditory system of the rat. J Comp Neurol 404, 52-63. (Pubitemid 29021518)
13. Fransen, E., Verstreken, M., Verhagen, W.I., et al. (1999). High prevalence of symptoms of Meniere's disease in three families with a mutation in the COCH gene. Hum Mol Genet 8, 14251429. (Pubitemid 29374075)
14. Galimberti, D., Scarpini, E., Venturelli, E., Strobel, A., Herterich, S., Fenoglio, C., Guidi, I., Scalabrini, D., Cortini, F., Bresolin, N., Lesh. K.P., and Reif, A. (2008). Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29, 1359-1365. (Pubitemid 351970600)
15. Glenn, C.L., Wang, W.Y., and Morris, B.J. (1999). Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension 33, 927-932. (Pubitemid 29186386)
16. Gonzalez-Gay, M.A., Llorca, J., Sanchez, E., Lopez-Nevot, M.A., Amoli, M.M., Garcia-Porrua, C, Ollier, W.E.R., and Martin, J. (2004). Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 43, 1182-1185. (Pubitemid 39232826)
17. Jia, S., Ni, J., Chen, S., Jiang, Y., Dong, W., Gao, Y. (2011). Association of the pentanucleotide repeat polymorphism in NOS2A promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol 30, 117-122.
18. Kawaguchi, S., Hagiwara, A., and Suzuki, M. (2008). Polymorphic analysis of the heat-shock protein 70 gene (HSPA1A) in Meniere's disease. Acta Otolaryngol 128, 1173-1177.
19. Kleinert, H., Schwarz, P.M., and Forstermann, U. (2003). Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384, 1343-1364. (Pubitemid 37508640)
20. Koo, J.W., Oh, S.H., Chang, S.O., Park, M.H., Lim, M.J. Yoo, T.J., and Kim, C.S. (2003). Association of HLA-DR and type II collagen autoimmunity with Meniere's disease. Tissue Antigens 61, 99-103. (Pubitemid 36286756)
21. Kun, J.F., Mordmuller, B., Lell, B., Lehman, L.G., Luckner, D., and Kremsner, P.G. (1998). Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351, 265-266. (Pubitemid 28043956)
22. Lopez-Escamez, J.A., Saenz-Lopez, P., Acosta, L., Moreno, A, Gazquez, I., Perez-Garrigues, H. Lopez-Nevot, A., and Lopez- Nevot, M.A. (2010). Association of a functional polymorphism of PTPN22 encoding a lymphoid protein phosphatase in bilateral Meniere's disease. Laryngoscope 120, 103-107.
23. Lopez-Escamez, J.A., Vilchez, J.R., Soto-Varela, A., Santos-Perez, S., Perez-Garrigues, H., Aran, I., and Lopez-Nevot, M.A. (2007). HLA-DRB1 1101 allele may be associated with bilateral Meniere's disease in southern european population. Otol Neurotol 28, 891-895. (Pubitemid 47511562)
24. Lynch, M., Cameron, T.L., Knight, M., Kwok, T.Y., Thomas, P., Forrest, S.M., Giersch, A.B., Briggs, R.J., and Pyman, B.C. (2002) Structural and mutational analysis of antiquitin as a candidate gene for Meniere disease. Am J Med Genet 110, 397399. (Pubitemid 34701058)
25. MacMicking, J., Xie, Q.W., and Nathan, C. (1997). Nitric oxide and macrophage function. Ann Rev Immunol 15, 323-350. (Pubitemid 27169284)
26. Merchant, S.N., Adams, J.C., and Nadol, J.B. (2005). Pathophy- siology of Meniere syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26, 74-81. (Pubitemid 40130213)
27. Mhatre, A.N., Jero, J., Chiappini, I., Bolasco, G., Barbara, M., and Lalwani, A.K. (2002) Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere's disease. Hear Res 170, 59-69.
28. Michel, O., Hess, A., Su, J., Bloch, W., Stennert, E., and Addicks, K. (2000). Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic cochlea of guinea pigs. Hear Res 143, 23-28. (Pubitemid 30193367)
29. Momin, S.R., Melki, S.J., Alagramam, K.N., and Megerian, C.A. (2010). Spiral ganglion loss outpaces inner hair cell loss in endolymphatic hydrops. Laryngoscope 120, 159-165.
30. Monsell, E.M., Balkany, T.A., Gates, G.A., Goldenberg, R.A., Meyerhoff, W.L., and House, J.W. (1995). Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 113, 181-185.
31. Motallebipour, M., Rada-Iglesias, A., Jansson, M., and Wadelius, C. (2005). The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding. Mol Vision 11, 950-957. (Pubitemid 41645672)
32. Pacher, P., Beckman, J.S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87, 315424. (Pubitemid 46217686)
33. Reif, A., Herterich, S., Strobel, A., Ehlis, A.C., Saur, D., Jacob, C.P., Wienker, T., Topner, T., Fritzen, S., Walter, U., Schmitt, A., Fallgatter, A.J., and Lesch, K.P. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11, 286-300.
34. Reif, A., Jacob, C.P., Rujescu, D., Herterich, S., Lang, S., Gut- knecht, L., Baehne, C.G., Strobel, A., Freitag, C.M., Giegling, I., Romanos, M., Hartmann, A., Rosler, M., Renner, T.J., Fall- gatter, A.J., Retz, W., Ehlis, A.C., and Lesh, P. (2009). Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66, 4150.
35. Rife, T., Rasoul, B., Pullen, N., Mitchell, D., Grathwol, K., and Kurth, J. (2009). The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease. J Neurosci Res 87, 2319-2325.
36. Ruel, J., Wang, J., Rebillard, G., Eybalin, M., Lloyd, R., Pujol, R., and Puel, J.L. (2007). Physiology, pharmacology and plasticity at the inner ear hair cell synaptic complex. Hear Res 227, 1927.
37. Sanchez, E., Lopez-Escamez, J.A., Lopez-Nevot, M.A., Lopez-Nevot, A., Cortes, R., and Martin, J. (2004). Absence of COCH mutations in patients with Meniere disease. Eur J Hum Genet 12, 75-78. (Pubitemid 38180973)
38. Saur, D., Seidler, B., Paehge, H., Schusdziarra, V., and Allescher, H.D. (2002). Complex regulation of human neuronal nitric- oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J Biol Chem 277, 25798-25814.
39. Saur, D., Vanderwinden, J.M., Seidler, B., Schmid, R.M., De Laet, M.H., and Allescher, H.D. (2004). Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci USA 101, 1662-1667. (Pubitemid 38234211)
40. Shinkai, T., Ohmori, O., Hori, H., Nakamura, J. (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7, 560-563.
41. Taylor, B.S., de Vera, M.E., Ganster, R.W., Wang, Q., Shapiro, R.A., Morris, S.M., Jr., Billiar, T.R., and Geller, G.A. (1998). Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273, 15148-15156. (Pubitemid 28272813)
42. Teggi, R., Lanzani, C., Zagato, L., Delli Carpini, S., Manunta, P., Bianchi, G., and Bussi, M. (2008). Gly460Trp alpha-ad- ducin mutation as a possible mechanism leading to endo- lymphatic hydrops in Meniere's syndrome. Otol Neurotol 29, 824-828.
43. Usami, S., Takahashi, K., Yuge, I., Ohtsuka, A., Namba, A., Abe, S., Fransen, E., Patthy, L., Otting, G., and Van Camp, G. (2003). Mutations in the COCH gene are a frequent cause of autoso- mal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease. Eur J Hum Genet 11, 744-748. (Pubitemid 37337056)
44. Warpeha, K.M., Xu, W., Liu, L., Charles, I.G., Patterson, C.C., Ah-Fat, F., Harding, S., Hart, P.M., Chakravarthy, U., Hughes, A.E. (1999). Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 13, 1825-1832. (Pubitemid 29473345)
45. Xu, W., Humphries, S., Tomita, M., Okuyama, T., Matsuki, M., Burgner, D., Kwiatkowski, D., Liu, L., and Charles, I.G. (2000a). Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. Nitric Oxide 4, 379-383. (Pubitemid 30664031)
46. Xu, W., Liu, L., Emson, P., Harrington, C.R., McKeith, I.G., Perry, R.H., Morris, C.M., and Charles, I.G. (2000b). The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport 11, 297-299. (Pubitemid 30074637)